Navigation Links
DW Healthcare Partners Forms Best in Class Organization with ClinPro Inc. and Pacific Data Designs, LLC
Date:11/6/2008

SALT LAKE CITY, Nov. 6 /PRNewswire/ -- DW Healthcare Partners ("DWHP") today announced completion of an investment in Pacific Data Designs, LLC ("PDD") and ClinPro Inc. Both companies are experienced contract research organizations ("CROs") supporting the pharmaceutical, biotechnology, medical device industries.

This investment will create an organization that is a best in class market leader in the CRO market specializing in Data Management and Statistical/Programming services to the Biotech, Medical Device, and Pharmaceutical industries. The mission is to apply the combined professional knowledge, staff, technology and skills to support and assist clients in advancing and accelerating their therapeutic clinical drug development initiatives.

"We believe both ClinPro and PDD have outstanding expert staff and a superior service offering in the market," said Doug Schillinger, Managing Partner at DW Healthcare Partners. "We are thrilled with the opportunity to have PDD and ClinPro join forces. Both companies have established reputations for excellence and are well positioned to benefit from increased outsourcing from drug sponsors during clinical and post-marketing trials."

The yet to be named combined company is led by Chief Executive Officer, Dr. Denis Lin, who successfully led another CRO market segment company in DWHP's portfolio.

"The management team is excited about the opportunity to expand its working relationship with DW Healthcare Partners," said Dr. Lin. "The opportunity to merge PDD and ClinPro, with identical philosophy in terms of serving clients expertly is unique. We believe the combined company will be able to offer better services because of the increased depth of knowledge, expertise, experience and capacity. Furthermore with the bi-coastal locations we will be closer to our clients and potential clients."

Jean Pineault is the Chief Operating Officer of PDD and Doron Steger is the Chief Executive Officer of C
'/>"/>

SOURCE DW Healthcare Partners
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. United Healthcare Workers Win New Contract with Horizon West
2. HMS Holdings Corp. to Present at Credit Suisse Annual Global Healthcare Conference
3. Healthcare Pioneer Dr. Ralph Snyderman to Receive Frost & Sullivans Lifetime Achievement Award
4. N.J. Hospitals, Military and Veterans Affairs Join Broad Effort to Improve Returning Vets Healthcare
5. BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference
6. Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare
7. 360 Healthcare Staffing Announces Agreement With BlueSky Medical Staffing Software
8. LocumTenens.com Finds Psychiatrists are Neutral on Universal Healthcare
9. Cell Therapeutics, Inc. (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
10. Nations Leading Healthcare Providers, Unions to Share Solutions With Congressional Leaders for Healthcare Crisis
11. Groseth Rejoins EMSI to Lead Healthcare Services Sales

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... rising incidence of obesity could counter recent ...c. 2 (HealthDay News) -- The overall health of the...decades, largely because people have quit smoking ...ght soon be wiped out if the rising obesity rates ...urrent trends in both smoking and obesity continue...
(Date:12/2/2009)...tches now available, many more to come, NIH direct...ay News) -- Thirteen stem cell lines have been ad...er-funded research, and many more such lines will ...unced Wednesday. , These are the first addition... funded by the U.S. National Institutes of Health ...
(Date:12/2/2009)..., WHITE PLAINS, N.Y., Dec. 2 /PRNewswire-USNewswir...nt their findings in blood cancer research at the ...ence in New Orleans December 4-8, 2009. ,, Thr...phoma Society (LLS) experts, including Chief Medic...President of Patient Services Hildy Dillon, and Vi...
(Date:12/2/2009)..., PHILADELPHIA, Dec. 2 Independenc...benefits contract with Lincoln Financial Group. IB... for approximately 10,000 Lincoln Financial Group ...he nation. The Lincoln plan offerings will include...ans. ,, "I know I speak for all of us at Indepe...
(Date:12/2/2009)...MAJoseph Balboni loves sports. An avid tennis play...r-old insurance agent became increasingly frustrat...onus, a degenerative eye disorder. Unable to retur...s, he faced the prospect of a corneal transplant t...ee years ago, Balboni discovered an alternative tr...
Breaking Medicine News(10 mins):Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:Brandeis studies evaluate visionary approach to improving eyesight 2
...s from Netherlands have found out that certain ord...inal drugs can cause deaths from cardiac arrest. ...pean Heart Journal, said that the non-cardiac drug...n prolong the duration of electrical activity that...
...rch report done by Swedish scientists its said tha...stage of prostate cancer than to wait and see if t...rostate cancer, also known as prostatectomy, is a ...an watching and waiting the cancer in the prostate...
...rug Administration (FDA) of US had approved the fi...ic fibrosis. The test is called Tag-It Cystic...the blood and detect genes that carry the strains ... who are not having the disease but are the carrie...
...ne by Italian researchers says that how long women...hey are born in. The research says that when the w...d by the time of their birth. The study had l... The results of the study show that the averag...
...d been associated to cardiovascular diseases and r...coronary artery aneurysms. Studies have always ...e abuse on the health of the person. The new study...ce of heart aneurysms. Aneurysm is a ballooni...
...nd Drug Administration (USA) had approved Baraclud...ng patient with chronic hepatitis B in adults.// ...rogress of the disease by interfering with the rep... drug called lamivudine. The results of the study ...
Other Medicine News:
(Date:12/2/2009)..., LUND, Sweden, December 2 Der...atology and wound healing company "Pergamum" -,tod...ng results from a,clinical Phase I/IIa study. Derm...e (AMP) treatment for atopic dermatitis. Atopic de...ere dry skin and the skin,s weakened barrier,funct...
(Date:12/2/2009)..., Md., Dec. 2 Novavax, I...ial results from the first stage of a two-stage pi...unogenicity of the company,s 2009 H1N1 virus-like ...x is conducting this study in collaboration with A...on of the vaccine in Mexico and potentially other ...
(Date:12/2/2009)...RK, Dec. 2 Keryx Biophar... that the U.S. Food and Drug Administration (FDA) ...erifosine), the Company,s novel, potentially first...e phosphoinositide 3-kinase (PI3K)/Akt pathway, fo...eloma. ,, The Fast Track program of the FDA i...
Breaking Medicine Technology:Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4BridgePoint Medical 28R 29 Receives European CE Mark for Stingray 28R 29 and CrossBoss 28TM 29 for Opening Completely Blocked Arteries 6470 1BridgePoint Medical 28R 29 Receives European CE Mark for Stingray 28R 29 and CrossBoss 28TM 29 for Opening Completely Blocked Arteries 6470 2Depression May Up Death Risk to That of Smoking 61948 1Depression May Up Death Risk to That of Smoking 61948 2Study highlights from November issue of GIE 3A Gastrointestinal Endoscopy 61945 1Study highlights from November issue of GIE 3A Gastrointestinal Endoscopy 61945 2Study highlights from November issue of GIE 3A Gastrointestinal Endoscopy 61945 3Study highlights from November issue of GIE 3A Gastrointestinal Endoscopy 61945 4Study highlights from November issue of GIE 3A Gastrointestinal Endoscopy 61945 5
...(ASCP), MA Ed ,Contributing Editor , ,Posi... healthcare accrediting bodies for the past few ye...rdware and software were beyond the reach of the a...ltiple vendors with devices that can be integrated... systems are better for small facilities, while ot...
... M.D., Ph.D. Harvard Medical School ,Contributin...d 40,000 deaths per year, breast cancer undoubtedl... problems. Recently, efforts to develop early det...e important progress. This is particularly true a...n expression have translated into new diagnostic t...
Other Medicine Technology:Managing Preanalytical Processes for Patient Safety 2Managing Preanalytical Processes for Patient Safety 3Managing Preanalytical Processes for Patient Safety 4Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 3
Paracheck Pf (P. falciparum) Rapid Test (Dipstick)
KAT-Quick Malaria test
Malaria P.f. Rapid Test Device
Core Malaria Pf
Medicine Products: